AVNR
{"sector":"Healthcare","industry":"Drugs","symbol":"AVNR","company_name":"AVANIR PHARMACEUTICALS","exchange":"NASDAQ"}AVNR Articles
Avanir Pharmaceuticals announced that it has entered into a definitive agreement with Otsuka Pharmaceutical for a $17.00 per share buyout.
Published:
A new research piece from Cantor Fitzgerald highlights the stocks expected to see the biggest number of shares changing hands on Friday's Russell 2000 rebalancing.
Published:
Avanir Pharmaceuticals posted amazing gains on Monday following the announcement of a successful Phase 1 trial, but is it now fully valued?
Published:
Last Updated:
Avanir Pharmaceuticals announced positive Phase 2 results for its drug candidate AVP-923, a potential new therapy for patients with Alzheimer’s disease.
Published:
Thinkstock24/7 Wall St. routinely reviews dozens of analyst research reports each morning of the week. At the end of each week, there is a realization that some stood out handily over most reports....
Published:
Last Updated:
These are the top analyst upgrades, downgrades and initiations from Wall Street for Friday, May 2, 2014. They include Avanir, Avon, Broadcom, LinkedIn, Oracle and Wynn Resorts.
Published:
ThinkstockAvanir Pharmaceuticals, Inc. (NASDAQ: AVNR) is seeing a late day surge on Wednesday after news broke that the company has prevailed in a patent fight covering NUEDEXTA. This drug remains...
Published:
ThinkstockWith the top stocks in the market exploding in price due to the recent rally, we wanted to scan across our research universe for some lower priced names that could have significant upside....
Published:
Once again, the analysts at Piper Jaffray are conducting extensive management meetings with the companies they cover. Here are the seven top biopharma stocks to buy now, according to Piper Jaffray.
Published:
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Tuesday morning. Arcelor Mittal (NYSE: MT) Started as Equal Weight at...
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Tuesday morning. Ashland Inc. (NYSE: ASH) Reiterated Buy with $79 target at Argus....
Published:
Last Updated:
Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves in shares of AVANIR Pharmaceuticals (NASDAQ: AVNR), Brocade Communications...
Published:
Active traders and day traders have many stocks to choose from this Wednesday morning. We are tracking news and moves in shares of Avanir Pharmaceuticals (NASDAQ: AVNR), Human Genome Sciences,...
Published:
Last Updated:
Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves in shares of Alcatel-Lucent (NYSE: ALU), Avanir Pharmaceuticals (NASDAQ:...
Published:
Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves in shares of Ambac Financial Group, Inc. (NYSE: ABK), Angiotech Pharmaceuticals...
Published:
Last Updated: